Showing results (1631-1640 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 1, 2001
The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation modelJ McDonnell, W K Redekop, N van der Roer, et al.Pharmacoeconomics|April 17, 2001
Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patientsA D Griffin, A S Perry, D M FlemingPharmacoeconomics|October 17, 2002
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthmaKetan Sheth, Rohit Borker, Amanda Emmett, et al.Pharmacoeconomics|November 29, 2002
Developing the revised NICE appraisal technical guidance to manufacturers and sponsors: opportunity or threat?Rod S Taylor, John Hutton, Anthony J CulyerPharmacoeconomics|November 30, 2002
The value of improving the productivity of the drug development process: faster times and better decisionsJoseph A DiMasiPharmacoeconomics|November 30, 2002
Returns on research and development for 1990s new drug introductionsHenry Grabowski, John Vernon, Joseph A DiMasiPharmacoeconomics|November 30, 2002
A profile of the health sector in the United StatesGrace-Marie TurnerPharmacoeconomics|November 30, 2002
National Institute for Clinical Excellence (NICE): Is economic appraisal working?Adrian Towse, Clive PritchardPharmacoeconomics|February 8, 2000
Pharmacoeconomics and health policy. Current applications and prospects for the futureP E Greenberg, A Arcelus, H G Birnbaum, et al.Pharmacoeconomics|February 8, 2000
Linking health-related quality-of-life indicators to large national data setsJ A Rizzo, J L SindelarPageof 336